Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act
Cognitive benefits are also significant
Bibcode:2020Anima..10.1855G
Research Use Only This product is sold strictly for laboratory and research use only
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
US$ 20.15
US$ 20.27
US$ 20.21
US$ 26.40
US$ 20.60
US$ 24.50
US$ 26.27
US$ 22.28
